Skip to content

Nuvalent, Inc. NUVL Other Working Capital

Other Working Capital at other companies

ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$16K-93.4%
Exelixis logo
ExelixisEXEL
$2.02M-57.8%
Incyte logo
IncyteINCY
-$12.77M-141%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
-$3.9M-160%
Eli Lilly logo
Eli LillyLLY
-$175M-137%
ALN
Alnylam PharmaceuticalsALNY

Other financials

Income statement

See full
Operating income-$119.4M-25.9%
Net income-$109.3M-29.2%
EPS (diluted)-$1.39-17.8%

Balance sheet

See full
Cash & equivalents$159.7M+32.2%
Total equity$1.2B+16.2%
Total assets$1.3B+20.4%

Cash flow

See full
Operating cash flow-$92.4M-68.5%

Valuation

See full
Market cap$9.77B+58.6%

Returns & leverage

See full
Return on equity-41.2%+7.5pp
Current ratio16.1×+1.7×

Where this comes from

Reported directly by Nuvalent, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.

The official record: Nuvalent, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvalent, Inc.'s other working capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvalent, Inc.'s other working capital?
Nuvalent, Inc. (NUVL) reported other working capital of -$120K in Q1 2026.
How has Nuvalent, Inc.'s other working capital changed year-over-year?
Nuvalent, Inc.'s other working capital decreased by 275.0% year-over-year, from -$32K to -$120K.
What does other working capital mean?
Net change in working capital items not separately classified — a residual balancing item.